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Endoscopy
AbsTrACT
Objective To establish the likely accuracy of pH testing to 
identify gastric aspirates at different pH cut-offs to confirm 
nasogastric tube placement.
Methods This prospective observational study included 
a convenience sample of adult patients who had two 
(one fresh and one frozen) gastric and oesophageal 
samples taken during gastroscopy or two bronchial 
and saliva samples taken during bronchoscopy. The 
degree of observer agreement for the pH of fresh and 
frozen samples was indicted by kappa (k) statistics. The 
sensitivities and specificities at pH ≤5.5 and the area 
under the receiver operating characteristics (ROC) curve 
at different pH cut-offs were calculated to identify gastric 
and non-gastric aspirates.
results Ninety-seven patients had a gastroscopy, 106 a 
bronchoscopy. There was complete agreement between 
observers in 57/92 (62%) of the paired fresh and frozen 
gastric samples (k=0.496, 95% CI 0.364 to 0.627). The 
sensitivity of a pH ≤5.5 to correctly identify gastric samples 
was 68% (95% CI 57 to 77) and the specificity was 
79% (95% CI 74 to 84). The overall accuracy to correctly 
classify samples was between 76% and 77%, regardless 
of whether patients were taking antacids or not. The area 
under the ROC curve at different pH cut-offs was 0.74.
Conclusion The diagnostic accuracy of pH ≤5.5 to 
differentiate gastric from non-gastric samples was low, 
regardless of whether patients were taking antacids or 
not. Due to the limited accuracy of the pH sticks and the 
operators’ ability to differentiate colorimetric results, there 
is an urgent need to identify more accurate and safer 
methods to confirm correct placement of nasogastric 
tubes.
IntroductIon
Nasogastric tube (NGT) feeding is recom-
mended to provide nutrition and hydration 
to patients unable to swallow. Every year, 
approximately 790 000 adults and children 
in the UK require to be fed by NGT to 
avoid malnutrition and dehydration and to 
give essential medications.1 However, if the 
NGT is not positioned in the stomach or is 
dislodged in the oesophagus, nasopharynx 
or bronchial tract it can result in serious 
harm, including aspiration pneumonia, 
pulmonary haemorrhage, pneumothorax 
and death.1–5 The Department of Health in 
the UK has identified that deaths by NGT 
misplacement should be ‘never events’.3 
However, 3%–4% of NGTs are misplaced 
summary box
What is already known about this subject?
 ► Testing the pH of gastric aspirate to show pH ≤5.5 
is recommended first-line test to confirm correct 
placement of nasogastric tubes and reduce the risk 
of potentially fatal aspiration.
 ► False positive readings may occur if the nasogastric 
tube is misplaced in the oesophagus or false nega-
tive readings (pH >5.5) may occur in patients who 
receive antacid medications, which can delay feed-
ing while waiting for the second-line test, a chest 
X-ray.
 ► There are limited numbers of studies that have ex-
amined the different pH cut-offs of gastric, oesoph-
ageal, saliva and bronchial aspirates.
What are the new findings?
 ► Compared with studies that have taken aspirate di-
rectly from the nasogastric tube, patients undergo-
ing scope procedures had a lower sensitivity at the 
pH cut-off ≤5.5 for identifying gastric aspirates for 
the whole group and in the presence and absence of 
antacid medications.
 ► Two-thirds of oesophageal aspirates had a pH cut-
off  ≤5.5, demonstrating considerable overlap with 
the gastric aspirates in this population.
 ► The pH readings between 4.5 and 6.0 provided the 
greatest overall accuracy, however there was only 
moderate agreement between observers at pH 
readings ≥5.0.
How might it impact on clinical practice in the 
foreseeable future?
 ► Current guidelines and training strategies need to be 
updated to better support healthcare professionals 
to accurately insert and check the position of naso-
gastric tubes.
 ► Further research is urgently required to develop nov-
el or a combination of low-cost bedside tests, which 
would  confirm nasogastric tube placement, and 
would be safer, easy to use, reduce the need for ex-
pensive X-rays and improve patient outcomes.
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every year and the number of serious incidents 
reported has increased by more than 60% between 
2014 and 2017, which calls into question current NGT 
testing methods.4 5 
Current healthcare guidelines recommend that the 
first-line test to confirm correct NGT placement prior 
to giving food or medications must be that the pH of 
an NGT aspirate is ≤5.5 (acidic).6 Nevertheless, false 
positive readings might occur if the tube is misplaced 
in the oesophagus or false negative readings (pH >5.5) 
may occur in patients who secrete less gastric acid, 
because of antacid medications, achlorhydria or buff-
ering by NGT feeds.7 8 Furthermore, aspirate may not 
be obtained immediately, which can lead to signifi-
cant delays to feeding while waiting for a second-line 
test, most often a chest X-ray, to check the NGT posi-
tion.9 Although, the chest X-ray is often regarded as 
the gold standard test, misinterpretation of X-rays has 
been reported as causing more cases of serious harm 
and death due to NGT misplacement than false pH 
readings (45% vs 8%).6 Furthermore, X-rays cannot 
be repeated very often without risking excessive radia-
tion and they have cost and resource implications, and 
can result in significant delays to feeding.10 It has been 
suggested that modified NGTs with external magnetic, 
electromagnetic guidance systems or fibre-optic capa-
bilities could be used to determine real-time NGT 
location and help prevent misplacement.11–13 However, 
these devices have yet to be implemented because they 
require expensive equipment and extensive training to 
interpret findings.14 Moreover, lung misplacements can 
still occur using these devices due to associated prob-
lems of malfunctioning, calibration and misinterpreta-
tion, therefore these methods are not recommended as 
stand-alone tests.15
The pH of lung aspirate is more often alkaline 
(ie, >pH 7), but could at least theoretically be acidic 
as a result of aspiration of gastric fluid or in situ 
build-up of lactic acid during infection or hyper-
ventilation.16 17 Measuring end-tidal carbon dioxide 
(ETCO2) in the aspirated air using capnography or 
colorimetric test can be used to exclude NGT place-
ment into the lungs rather than confirm placement in 
the stomach. However, these tests can result in false 
positive results in 16% of cases when compared with 
X-rays.18 They are also unable to positively confirm 
misplacement of the NGT in the mouth, nasopharynx 
or oesophagus.19
To date, the studies examining the different pH 
cut-offs of gastric aspirates are limited by the small 
number of aspirates obtained from the NGT, the lack 
of a robust gold standard to ensure gastric placement, 
the differences in the comparative non-gastric samples 
and methods of pH (stick vs metre) measurements.20 21 
There are also very few studies that have examined the 
pH of oesophageal and/or saliva.22 Therefore, the aim 
of this study was to provide more precise estimates of the 
sensitivity and specificity using the entire range of pH 
stick cut-offs to distinguish between gastric, oesophageal, 
saliva and bronchial secretions.
Methods
study design, setting and ethics
A prospective observational study was conducted in 
two UK teaching hospitals between 1 November 2014 
and 20 December 2016 to compare the pH of aspirates 
obtained during gastroscopy or bronchoscopy from 
the stomach, oesophagus, mouth and lung. The study 
was reported as recommended by the STAndards for 
the Reporting of Diagnostic accuracy studies (STARD) 
guidelines.23 
Participants
A convenience sample of adults over the age of 16 who 
required a first routine gastroscopy or bronchoscopy. 
Consent was obtained from all patients who volun-
teered to have samples taken during the procedure 
and data regarding their use of antacid medication and 
confounding factors that might affect the pH of any aspi-
rate results were recorded. Patients were excluded if they 
lacked mental capacity or the specimens were consid-
ered high risk, including known tuberculosis, blood or 
airborne viruses.
data collection
Prior to the procedure, patients were asked to fast for at 
least 4 hours and data regarding the use of antacid medi-
cation or conditions/surgery that might affect the pH of 
any aspirate results were recorded. During the routine 
gastroscopy, two of each type of sample (oesophageal 
and gastric) were suctioned and collected by the oper-
ator. Patients undergoing bronchoscopy were asked to 
spit saliva into two labelled universal containers prior to 
the procedure and two lung samples were then obtained 
during the procedure. The reference standard was direct 
confirmation of the type of aspirate, confirmed by the 
operator undertaking the gastroscopy or bronchoscopy, 
which would not be possible if it was taken directly from 
an NGT. At the end of each of the procedures a research 
nurse tested two samples using a pH stick. As the testing 
of fresh samples during endoscopy could not be blinded 
to the source of aspirate we froze the remaining two 
samples to −20°C from each location for blinded pH 
testing. At the end of data collection for the main study, 
the frozen samples were defrosted thoroughly for 4 hours 
and were allowed to reach room temperature prior to 
being tested by a research nurse who was not previously 
involved in testing the specimens. The samples were then 
destroyed after the second testing phase.
The pH stick was supplied by Enteral UK, North Duff-
ield, UK. The pH sticks scale ranges from 2.0 to 9.0 with 
three colour blocks in intervals of 0.5 pH units. The 
research nurses followed a standard operating proce-
dure to ensure that each specimen was pipetted from the 
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container to cover the pH stick and the colours of the 
sticks were compared after 60 s with that on the container.
Patient involvement
No patients were involved in the design or implementa-
tion of this study. However, the findings, recommenda-
tions and implications of the project will be disseminated 
in accessible formats suitable for the relevant patient 
community.
Analyses
Descriptive statistics included the median, IQR, percent-
ages, frequencies and 95% CIs. The McNemar’s test was 
used to compare paired categorical data and kappa (k) 
statistic was used to indicate the observer agreement 
between the paired fresh and frozen samples. Missing 
data were excluded from analysis and a p value of <0.05 
was considered statistically significant. Diagnostic data 
included analyses of the sensitivity, specificity, positive/
negative predictive values (PV), and the positive/nega-
tive likelihood ratios (LR) of the pH tests for each type of 
sample. The cut-off values were aligned to the agreed clin-
ical standards for testing pH (ie, ≤5.5 was classified as a 
gastric sample, whereas >5.5 was classified as a non-gastric 
sample). The receiver operating characteristics (ROC) 
were analysed for gastric versus non-gastric samples to 
determine the relationship between sensitivity and speci-
ficity and the area under the curve. All data analyses were 
performed using SAS V.9.4 (Statistical Analysis System 
Institute).
A sample size of 100 for each sample was estimated 
based on the 95% CIs and the majority of gastric aspirates 
having a pH ≤5.5. However, the sample size could vary 
depending on how many patients have gastric secretions 
with a pH >5.5, as this was unknown we arbitrarily chose 
4% where pH might misclassify the samples. We expected 
no false positive samples when testing saliva or bronchial 
aspirate, which would give specificity of 100% (95% CI 97 
to 100). Therefore, we estimated that 200 patients each 
having four samples (fresh and frozen) taken during 
either gastroscopy (gastric and oesophageal samples) or 
bronchoscopy (bronchial and saliva samples) procedures 
would be required, providing a total of 800 pH tests.
results
In total, 211 patients were recruited to the study, 
however, eight patients were removed as their samples 
were wrongly labelled and could not be positively identi-
fied. Of the 203 remaining patients: 95 (47%) were male; 
97 (48%) underwent a gastroscopy; and 106 (52%) a 
bronchoscopy. Eighty-three (41%) patients were taking 
antacid medication (2% were taking H2 antagonists and 
98% proton pump inhibitors) prior to the gastroscopy 
(42/97, 43%) or bronchoscopy (41/106, 39%). From 
the expected 812 samples (ie, two fresh and two frozen 
Figure 1 STAndards for the Reporting of Diagnostic accuracy studies (STARD) diagram reporting the flow of participants 
through the study.
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samples from the 203 participants), 717 (88%) samples 
were suitable for testing. Of the 390 fresh and 327 frozen 
samples, 16 were not collected during the procedure 
and 63 were not suitable for testing after the sample was 
defrosted. The numbers of fresh and frozen gastric and 
non-gastric samples at pH ≤5.5 and >5.5 are shown in 
figure 1.
distribution of the ph for each sample
Figure 2 shows the distribution of the pH for each type 
of sample. Predictably, the fresh gastric samples (n=96) 
had the lowest median pH of 2 (IQR 2.0–6.5), regardless 
of whether patients were taking antacids (n=42) or not. 
The oesophageal samples (n=90) had a median pH of 
5.0 (IQR 2.0–6.5) and the median pH was 7.0 for both 
bronchial and saliva samples. Importantly, 100% of the 
bronchial samples (n=103, IQR 6.5–7.0) and 98% of the 
saliva samples (n=101, IQR 6.5–7.0) had a pH >5.5.
Fresh versus frozen samples
There were no significant differences in the distribu-
tion of the discordant results between paired fresh 
and frozen gastric (McNemar’s test=0.14, p=0.7) and 
non-gastric (McNemar’s test=0.69, p=0.4) samples at 
the pH ≤5.5 cut-off. In fact, the agreement was good 
between the paired fresh and frozen samples at the 
pH cut-off ≤5.5: gastric (n=85/92, 92%); oesophageal 
(n=74/87, 85%); bronchial (n=63, 100%); and saliva 
(n=82, 100%) samples. However, when the individual 
paired fresh and frozen samples were compared between 
the observers there was only complete agreement in 
57/92 (62%) when testing the gastric samples (k=0.496, 
95% CI 0.364 to 0.627) and in 97/232 (42%) for the 
non-gastric samples (k=0.316, 95% CI 0.241 to 0.390). 
The differences between the observers more frequently 
occurred at pH readings ≥5.0, which included 28/92 
(30%) of the gastric and 121/232 (52%) of the non-gas-
tric fresh and frozen pairings (online supplementary files 
1 and 2).
Accuracy of the ph ≤5.5 cut-off
Table 1 shows the diagnostic accuracy of pH ≤5.5 for all 
samples and in the presence or absence of antacid medi-
cation to distinguish fresh gastric and non-gastric samples. 
The sensitivity to correctly identify gastric samples at 
pH ≤5.5 was 68% (95% CI 57 to 77) and the specificity 
was 79% (95% CI 74 to 84). Surprisingly, the sensitivity of 
the gastric pH was slightly higher in patients on antacids 
(71%, 95% CI 55 to 84) compared with the rest (65%, 
95% CI 51 to 77). The positive PV to predict the sample 
was gastric given a positive test (pH ≤5.5) was 52% (95% 
CI 45 to 58). The negative PV to predict the sample was 
non-gastric given a negative test (pH >5.5) was 88% (95% 
CI 85 to 91). The positive and negative LRs were 3.3 and 
0.4, respectively. The overall probability that the samples 
would be correctly classified was 76%–77%, regardless of 
whether patients were taking antacid medication or had 
other potentially confounding factors, including those 
with pernicious anaemia (n=3) and/or had previous 
gastric surgery (n=9).
Figure 2 Box plot showing the distribution of pH by sample type, including: median (midline); mean (◊); 25th and 75th 
percentiles (box); and the range, excluding outliers (bars).
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the sensitivity and specificity at different ph cut-offs
As expected, there was an increase in sensitivity at higher 
pH cut-offs, but this was at the expense of lowering the 
specificity. For these samples, the pH readings between 
4.5 and 6.0 provided the optimal balance between sensi-
tivities and specificities. There were no bronchial samples 
with a pH ≤6.0, but there were 59/90 (66%) oesophageal 
and two saliva samples that lowered the specificity of the 
test to 76% (95% CI 71 to 81). If a pH ≤4.5 was used the 
sensitivity fell to only 60% (95% CI 50 to 71), whereas the 
specificity increased to 86% (95% CI 82 to 90). Overall, 
the area under the ROC curve at different pH cut-offs to 
differentiate the gastric from the non-gastric samples was 
0.74 (figure 3, online supplementary file 3).
dIscussIon
This prospective study found that a cut-off of pH ≤5.5 
resulted in similarly low sensitivities for identifying gastric 
secretions in the whole group and in the subgroup on 
antacids or with other confounding factors who might 
be expected to have less gastric acid. The results of the 
current study are comparable to a recent study that 
found a sensitivity of 66% using a similar standard colori-
metric pH stick in gastric aspirates taken from an NGT.24 
However, earlier studies have estimated that this cut-off 
would provide slightly higher sensitivities of between 85% 
and 90% in patients not taking antacids or 73%–77% if 
antacid medication was present.25–27 Where aspirate is 
not obtained from the NGT, the overall sensitivity of the 
pH test has been reported to decrease to 66%.27 It was 
also reassuring that pH ≤5.5 was able to rule out all of the 
bronchial samples in the present study.
In this study, 66% of the oesophageal samples had a 
pH ≤5.5, demonstrating that there was considerable 
overlap with the gastric aspirates. This may have resulted 
from regurgitation of gastric secretions through the 
gastric sphincter during gastroscopy.28 However, if this 
occurred in patients receiving NGT feeding they would 
have been at risk of been fed into the oesophagus, which 
Figure 3 Receiver operating characteristic (ROC) curve to 
determine the diagnostic accuracy of different pH cut-offs for 
the fresh gastric sample versus the non-gastric samples.
Table 1 The proportion of fresh samples from different sources with pH ≤5.5 and the diagnostic accuracy of using this cut-off 
to detect gastric source overall, and in the presence or absence of prior antacid medication and confounding factors
Sample
All Antacid medication
No antacid
medication
All confounding
factors*
Number with pH ≤5.5/total n (%)
Gastric 65/96 (68) 30/42 (71) 35/54 (65) 32/44 (73)
Oesophageal 59/90 (66) 26/41 (63) 33/49 (67) 26/42 (62)
Saliva 2/101 (2) 2/40 (5) 0/61 (0) 2/43 (5)
Bronchial 0/103 (0) 0/41 (0) 0/62 (0) 0/45 (0)
Diagnostic test Gastric pH versus all other samples (95% CI)
Sensitivity % 68 (57, 77) 71 (55, 84) 65 (51, 77) 73 (57, 85)
Specificity % 79 (74, 84) 77 (69, 84) 81 (74, 86) 79 (70, 85)
PPV % 52 (45, 58) 52 (42, 61) 52 (43, 61) 53 (44, 62)
NPV % 88 (85, 91) 89 (83, 93) 88 (84, 91) 90 (83, 92)
PLR 3.3 (2.5, 4.2) 3.1 (2.1, 4.5) 3.4 (2.3, 4.9) 4.0 (2.4, 5.7)
NLR 0.4 (0.3, 0.6) 0.4 (0.2, 0.6) 0.4 (0.3, 0.6) 0.4 (0.3, 0.6)
Overall accuracy† % 76 (72, 81) 76 (68, 82) 77 (68, 82) 77 (70, 83)
*Confounding included antacid medication, pernicious anaemia or gastric surgery.
†Refers to the probability that the aspirate will be correctly identified.
NLR, negative likelihood ratio; NPV, negative predictive value; PLR, positive likelihood ratio; PPV, positive predictive value.
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could increase the risk of aspiration pneumonia (ie, a 
‘never event’).29 A third of the gastric aspirates also had a 
pH >5.5, which if taken from an NGT would have resulted 
in significant delays before essential nutrition, fluid and 
medication could be delivered while waiting to retest a 
few hours later or for X-ray confirmation of placement 
in the stomach.
Comparing the entire range of pH cut-off, the pH 
readings between 4.5 and 6.0 provided the greatest 
overall accuracy. However, we found that there was a 
lack of complete agreement between observers to differ-
entiate the fresh and frozen samples, particularly at pH 
readings >5.0. Previous studies have also reported that 
testers frequently have difficulties in differentiating 
between the small differences in the pH colours, partic-
ularly across the range 5–7, which is the vital range to 
determine whether to feed or not using an NGT.21 30 
A recent study reported that misinterpretation of pH 
readings occurred in 30% of pH readings of which 
12% were pH 6.0.9 These errors were equally common 
among both novice and experienced staff,9 reinforcing 
that visual inspection of the pH stick is unreliable. 
However, in this study we cannot discount that some of 
the samples pH may have been altered by freezing and 
defrosting of the samples.
strengths and limitations
A strength of the current study was the large number of 
aspirates that could be obtained from patients under-
going routine gastroscopy and bronchoscopy and in 
whom we could be certain of the source of the aspi-
rate. This approach was considered the best option 
to obtain bronchial and oesophageal aspirates, which 
have previously been under-reported or estimated from 
the literature.21 22 Furthermore, obtaining tube aspirate 
from the NGT is not possible in up to 46% of patients.9 
Although, a lack of aspirates will impact on the 
usability of the pH test, the aim of the current study was 
to explore the accuracy of pH cut-offs on the different 
types of aspirate, which would not have been verifiable 
from the NGT without additional X-rays. A potential 
limitation of using endoscopic procedures is that there 
may have been variability between the methods used to 
obtain the samples. The population undergoing scope 
procedure may also differ from those requiring naso-
gastric feeding. It was also expected that the majority 
of patients would have a fasting gastric pH <4.0, but 
in fact there was high prevalence of hypochlorhydria, 
particularly as it is more common in patients under-
going endoscopic investigations.31 32 The gastric pH 
results between those patients taking antacid medi-
cations or not may also be confounded by the fasting 
conditions and if medications were stopped prior to 
the procedure.33 Stopping antacids prior to the proce-
dure increases the risk of gastric acid rebound hyper-
secretion, which might explain our observation that 
those usually taking an antacid did not have a greater 
frequency of pH >5.5.34
Implications for practice
Currently, the recommended first-line test using the pH 
cut-off of ≤5.5 is able to safely exclude all bronchial aspi-
rates, though it does not exclude oesophageal samples. 
Therefore, it is recommended guidelines should 
include optimal strategies to prevent oesophageal 
misplacement or displacement.21 Overall, the accuracy 
of the pH sticks used in isolation was poor, which could 
be further hampered by the testers’ ability to differ-
entiate colorimetric results and/or ability to obtain 
aspirate. Consequently, effective training strategies are 
required to reduce misinterpretation of pH readings 
and highlight particular issues related to visual inspec-
tion, which could potentially be reduced by redesign of 
the colorimetric pH stick,9 the addition of biochemical 
markers,20 24 or comparing pH measured with both pH 
stick and metre.21 Other bedside methods, including 
measurement of the internal length of the NGT and 
ultrasound at the neck, may help prevent NGT position 
in the oesophagus as well as increase the probability 
of obtaining aspirate.20 35 At present, there are several 
bedside methods to verify NGT position, but they are 
not included in current health guidelines as there is 
limited evidence to support their effectiveness as stand-
alone tests.6 21 However, a combination of cost-effective 
bedside tests, both established and novel, used to check 
NGT position is likely to be more accurate and safer 
than one test in isolation.9
conclusIons
Ensuring patients are well nourished and hydrated to 
improve outcomes, experiences of care and reducing 
avoidable harm are international priorities. Therefore, 
further research into more accurate methods to differen-
tiate gastric from non-gastric tube placement, to reduce 
delays in feeding, X-rays, repeated NGT insertions, and 
associated healthcare costs is urgently required.
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